Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin resistance in dysglycaemia and type 2 diabetes
ACTRN12611001132932Phase 4Recruiting
- Sponsor
- RMIT University
- Start
- Feb 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin, clopidogrel and metformin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by RMIT University. Primary endpoint: Urinary 11-dehydro thromboxane B2 to creatinine ratio. Started Feb 2012; status: recruiting.
02
Drugs
aspirinclopidogrelmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12611001132932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001132932.